Quantification of the vitamin D receptor-coregulator interaction
Arnaud Teichert1, Leggy A Arnold, Steve Otieno
1Endocrine Unit, University of California, San Francisco, San Francisco, California 94121, USA.
Biochemistry
|February 3, 2009
Summary
The vitamin D receptor (VDR) interacts with coregulator proteins, influencing gene activity. Similar binding patterns were observed for both natural and synthetic ligands, aiding in developing targeted vitamin D therapies.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- The vitamin D receptor (VDR) is crucial for regulating genes involved in bone health, immunity, and hair growth.
- Ligand binding to VDR induces conformational changes, affecting corepressor and coactivator protein interactions essential for gene transcription.
Purpose of the Study:
- To comprehensively evaluate the interaction of VDR with various coregulator binding motifs.
- To compare VDR interactions with its natural ligand (1alpha,25(OH)(2)D(3)) and a synthetic agonist (LG190178).
Main Methods:
- Utilized a library of coregulator binding motifs to assess VDR interactions.
- Investigated VDR binding affinities in the presence of both 1alpha,25(OH)(2)D(3) and LG190178.
Main Results:
- VDR demonstrated high affinity for specific LxxLL motifs in SRC1, SRC2, SRC3, and DRIP205, a pattern distinct from other nuclear receptors.
- Binding affinity patterns were highly consistent between the natural ligand and the synthetic agonist LG190178.
- Hairless protein binds VDR via an LxxLL motif, repressing transcription irrespective of ligand presence.
Conclusions:
- The consistent VDR-coregulator binding patterns for both ligands suggest similar biological functions.
- Identified VDR binding patterns can predict tissue-specific functional differences based on coregulator expression.
- Findings facilitate the development of targeted modulators for tissue- and gene-specific vitamin D responses.
Related Concept Videos
Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Intracellular Hormone Receptors
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Protein-Drug Binding: Determination Methods
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

